Upon removal of insulin implants after 1 month, a recurrence of hyperglycemia was observed (Fig. 4C), and Kuma mutant mice still showed impaired glucose tolerance, which was not significantly different from those of the untreated group (Fig. 4D,E). The gene discussed is INS; the disease is Hyperglycemia.